علاج تمدد الأوعية الدموية الصدرية الأبهرية غير المتشقق في متلازمة مارفان مع إشراك جذر الأبهر

References

DOI: 10.1161/CIR.0000000000001106

Patients with Marfan syndrome develop aneurysms involving the aortic root (sinuses of Valsalva) and are at risk for aortic dissection.

In patients with Marfan syndrome, treatment with either a beta blocker or an ARB, in maximally tolerated doses (unless contraindicated), is recommended to reduce the rate of aortic dilation.

In patients with Marfan syndrome, the use of both a beta blocker and an ARB, in maximally tolerated doses (unless contraindicated), is reasonable to reduce the rate of aortic dilation.

View source ↗